A synthetic peptide for use as a blocking control in assays to test for specificity of TNNT2 antibody, Alternative Names: Troponin T Type 2 control peptide, Troponin T Type 2 antibody Blocking Peptide, Anti-Troponin T Type 2 Blocking Peptide, CMH2 Blocking Peptide, CMPD2 Blocking Peptide, MGC3889 Blocking Peptide, TnTC Blocking Peptide, cTnT Blocking Peptide, TNNT2 Blocking Peptide
TNNT2 is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in the gene encoding TNNT2 have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy.